Sign inJoin waitlistJoin the waitlist

Robert Belknap

Executive Director, Public Health Institute at Denver Health · Denver Health Medical Center

Credentials: · · · ·

History

Public Health Institute at Denver Health Center · Denver Health Medical Center
Present
University of Colorado School of Medicine
Present

Infectious Disease
University of Colorado School of Medicine
2003–2005
Internal Medicine
University of Colorado School of Medicine
1998–2001
Ohio State University College of Medicine
1994–1998

Research

Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
Systematic review or meta-analysis · MMWR Recommendations and Reports · 2020 · Last of 13 authors · 388 citations
Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States
American Journal of Respiratory and Critical Care Medicine · 2014 · 187 citations
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial
Annals of Internal Medicine · 2017 · First of 16 authors · 135 citations

RR
Randall Reves
17 papers
Adithya Cattamanchi
6 papers
Jason Stout
6 papers
Michelle Haas
6 papers
Payam Nahid
6 papers
Amanda Sammann
5 papers
Christopher Berger
5 papers · 1 as a fellow
David Dowdy
5 papers
CP
Connie Price
4 papers
Alison Beieler
3 papers
April Pettit
3 papers
CS
Carla Saveli
3 papers

Clinical trials

Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Principal investigator · Completed · Phase 3
Centers for Disease Control and Prevention
2012–2014
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Study chair · Recruiting · Phase 2, Phase 3
Centers for Disease Control and Prevention
2019–2029